What KBM Pharma does

KBM Pharma OÜ is a privately-held Estonian pharmaceutical services company headquartered in Tartu, founded in 1995 to serve pharmaceutical manufacturers seeking market access in the Baltic states of Estonia, Latvia, and Lithuania. The company operates an integrated service model that bundles four functions: regulatory affairs consulting (marketing authorization applications, renewals, variations, and local representation before the Estonian State Agency of Medicines), pharmacovigilance services (adverse reaction reporting, risk minimization, medical literature monitoring), GDP-licensed wholesale pharmaceutical distribution, and sales and marketing support including a flexible field sales force. Customers are primarily pharmaceutical manufacturers seeking turnkey entry into Baltic markets, served through a sales-led B2B go-to-market motion combined with print, digital and social media marketing.

The company's underlying operations are regulatory and logistics-driven rather than technology-driven. It holds a licensed GDP (Good Distribution Practice) wholesale distributor authorization and has built relationships with leading pharmaceutical wholesalers and pharmacy chains across the three Baltic countries, providing market coverage for pharmaceutical products, food supplements and medical devices. Beyond the core B2B services, KBM Pharma extends into direct-to-consumer distribution through the KBM Tervis e-commerce storefront (kbmtervis.ee), selling food supplements and medical devices to end consumers in Estonia. Revenue is generated through a mix of professional services fees for regulatory and marketing engagements and transaction-based wholesale distribution margins. Pricing is not publicly disclosed and the company maintains no disclosed external investors, parent company, or subsidiaries.

The leadership team consists of two board members: Jaak Koppel, who serves as Member of the Board and Executive Director, and Andres Kaup, who serves as Member of the Board. The company is privately held and founder/management-owned based on observed leadership structure, with no documented venture capital backing, M&A activity, funding rounds, or major leadership transitions in the available source material.

Name

KBM Pharma

Legal name

KBM Pharma OÜ

Website

https://kbmpharma.eu

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

KBM Pharma is a privately-held Estonian pharmaceutical services company offering integrated regulatory affairs, pharmacovigilance, marketing, and GDP-licensed distribution to pharmaceutical manufacturers across Estonia, Latvia, and Lithuania, with a complementary DTC e-shop for supplements.

Ownership category

akta.pro rank

Product category

Pharmaceutical Services (Regulatory Affairs, Pharmacovigilance, Distribution and Marketing)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD)

akta.pro secondary industry

Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

Keywords

• Pharmaceutical distribution
• Regulatory affairs consulting
• Pharmacovigilance services
• Pharmaceutical marketing
• Food supplement distribution

Headquarters

HQ city

Tartu

HQ country

Estonia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Regulatory Affairs Services: Consulting services for pharmaceutical companies including registration applications, pharmacovigilance support, and regulatory compliance. Services can be tailored for short-term projects or ongoing partnerships.
2. Pharmaceutical Distribution: GDP-compliant wholesale distribution of pharmaceutical products, food supplements and medical devices to pharmaceutical wholesalers and pharmacy chains across Estonia, Latvia and Lithuania.
3. Marketing Services: Sales and marketing solutions for pharmaceutical products, medical devices and food supplements provided to pharmaceutical manufacturers.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

KBM Pharma is a Baltic pharmaceutical services company that provides integrated regulatory affairs consulting (drug registration, pharmacovigilance, marketing authorization applications), GDP-licensed wholesale distribution of pharmaceuticals, food supplements and medical devices, and sales/marketing support for pharmaceutical manufacturers seeking market access in Estonia, Latvia, and Lithuania. The company also operates the KBM Tervis e-shop (kbmtervis.ee) for direct-to-consumer sales of food supplements and medical devices.

Product overview

KBM Pharma is a pharmaceutical services company established in 1995, offering an integrated portfolio of registration, marketing, and distribution services for pharmaceutical products, food supplements, and medical devices in Estonia, Latvia, and Lithuania. The company's core offerings include Regulatory Affairs Consulting (covering marketing authorization applications, renewals, and variations), Pharmacovigilance Services (national-level adverse reaction monitoring and risk minimization), Marketing and Distribution (GDP-licensed wholesale distribution with sales force support), and Product Registration services (for food supplements, medical devices, biocides, and special medicinal foods). The company also operates the KBM Tervis E-Shop for direct consumer access to food supplements and medical devices. Registration, marketing and distribution services are integrated to provide flexibility and effectiveness for pharmaceutical manufacturers.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Consulting Comprehensive regulatory affairs services including preparation and submission of marketing authorization applications, renewals, and variations to the Estonian State Agency of Medicines; local representation for Marketing Authorization Holders; and consulting on local legislation and requirements. Targeted at pharmaceutical manufacturers seeking Baltic market access.
• Pharmacovigilance Services National-level pharmacovigilance support including collection, translation and reporting of adverse reactions, quality complaints and special reportable situations; risk minimization material preparation; and medical literature monitoring. Targeted at pharmaceutical Marketing Authorization Holders requiring a Baltic pharmacovigilance partner.
• Marketing and Distribution (GDP-Licensed Wholesale) GDP-licensed wholesale distribution of pharmaceutical products, medical devices and food supplements with cost-effective sales and marketing solutions, providing market coverage through cooperation with leading pharmaceutical wholesalers and pharmacy chains across Estonia, Latvia and Lithuania. Targeted at pharmaceutical manufacturers seeking Baltic distribution and sales support.
• Product Registration Registration services for pharmaceutical products, food supplements, medical devices, biocides, and food for special medicinal purposes, including consulting on local legislation, product classification, labeling translation, and authority notifications. Targeted at manufacturers needing to register health-related products in Estonia and the wider Baltic region.
• KBM Tervis E-Shop Direct-to-consumer e-commerce platform selling food supplements and medical devices to Estonian consumers and healthcare professionals. Operated as a sub-brand at kbmtervis.ee.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• DHL Supply Chain (Life Sciences): Global contract logistics provider with a dedicated Life Sciences and Healthcare vertical offering GDP-compliant warehousing and distribution. DHL's life sciences logistics arm competes for the same manufacturer distribution mandates that KBM Pharma services in the Baltics.
• PHOENIX Group: Pan-European pharmaceutical wholesale and retail pharmacy group and parent of Tamro. PHOENIX represents the broader incumbent competitive backdrop against which KBM Pharma positions its regional wholesale and services offering.
• Alliance Healthcare: European pharmaceutical wholesaler and pharmacy distributor (part of Walgreens Boots Alliance). Alliance Healthcare serves the same manufacturer client base as KBM Pharma but at much greater geographic scale, posing a structural competitive risk for multi-country accounts.
• McKesson: Global pharmaceutical wholesale and healthcare services company. McKesson provides a competitive benchmark for pharma distribution economics and represents the type of well-capitalized incumbent that smaller regional distributors must contend with.
• Cencora: Global pharmaceutical distribution, consulting, and biopharma services company (formerly AmerisourceBergen). Cencora's PharmaLex and World Courier operations overlap with KBM Pharma's regulatory and distribution services, albeit at significantly larger scale.

Direct peers

• Tamro: Pharmaceutical wholesaler operating across the Baltic and Nordic markets, distributing medicines to pharmacies and healthcare providers. Tamro competes directly with KBM Pharma in the Baltic pharmaceutical wholesale channel and is a benchmark for regional GDP-compliant distribution.
• PharmaLex (Cencora PharmaLex): Specialized regulatory affairs and pharmacovigilance services provider serving pharmaceutical manufacturers globally, now part of Cencora. PharmaLex competes with KBM Pharma's regulatory affairs consulting arm for manufacturer clients seeking market-entry and lifecycle management support.
• Euroapotheca: Operates retail pharmacy chains across the Baltic states and adjacent markets. Euroapotheca is a direct channel counterpart to KBM Pharma's wholesale distribution and pharmacy chain partnerships in the same geography.

Regional players

• Eurotranspharma: European temperature-controlled pharmaceutical transport and distribution specialist operating primarily in France and Benelux with some cross-border reach. Eurotranspharma is a regional comparison point for KBM's GDP-compliant distribution capabilities in a different European geography.

Emerging players

• Pharmexon: Smaller European regulatory affairs and pharmacovigilance consulting firm serving pharmaceutical manufacturers. Pharmexon is a similarly scaled emerging services provider whose business model closely mirrors KBM Pharma's regulatory consulting arm.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KBM Pharma